Showing results (1051-1060 of 1,183) with videos related to

Sort By:
Pageof 119
Nature Communications|September 11, 2019
Environmental temperatures shape thermal physiology as well as diversification and genome-wide substitution rates in lizardsJoan Garcia-Porta, Iker Irisarri, Martin Kirchner, et al.
Journal of Geophysical Research. Planets|April 10, 2023
Winds at the Mars 2020 Landing Site. 2. Wind Variability and TurbulenceD Viúdez-Moreiras, M de la Torre, J Gómez-Elvira, et al.
Journal of Pain and Symptom Management|August 28, 2025
Proceedings of the First Neuropalliative Care Research Summit (NeuroCARES)C J Creutzfeldt, J Bogetz, C Candrian, et al.
Nature Communications|October 19, 2019
De novo and recessive forms of congenital heart disease have distinct genetic and phenotypic landscapesW Scott Watkins, E Javier Hernandez, Sergiusz Wesolowski, et al.
Frontiers in Oncology|October 3, 2022
Genomic landscape of advanced prostate cancer patients with <i>BRCA1</i> versus <i>BRCA2</i> mutations as detected by comprehensive genomic profiling of cell-free DNAUmang Swami, Raquel Mae Zimmerman, Roberto H Nussenzveig, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virusJuan Pu, Shuoguo Wang, Yanbo Yin, et al.
Pediatric Neurology|December 21, 2024
Neonatal Seizures and Associated Neurobehavioral Profiles in Preschool Age ChildrenAllyssa M Mattes, Renée A Shellhaas, Hannah C Glass, et al.
Nature Communications|October 4, 2023
Glycoproteomic landscape and structural dynamics of TIM family immune checkpoints enabled by mucinase SmEJoann Chongsaritsinsuk, Alexandra D Steigmeyer, Keira E Mahoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2023
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion MutationsMichael J Grant, Jacqueline V Aredo, Jacqueline H Starrett, et al.
Nature Communications|May 5, 2023
Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastomaEsther R Berko, Gabriela M Witek, Smita Matkar, et al.
Pageof 119